Park West Asset Management’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,100,000
Closed -$10.9M 103
2021
Q4
$10.9M Hold
1,100,000
0.22% 62
2021
Q3
$10.8M Hold
1,100,000
0.26% 71
2021
Q2
$11.1M Buy
+1,100,000
New +$11.1M 0.32% 75

Other funds holding PROK

Park West Asset Management's PROK Position: Q1 2022 in Review

Park West Asset Management sold out of ProKidney (PROK) in Q1 2022, closing a stake of 1,100,000 shares — an estimated $10.9M sold.

Park West Asset Management first reported a position in PROK in Q2 2021 and held it in 3 quarters. The position peaked at $11.1M in Q2 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.

  • Park West Asset Management reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
  • Park West Asset Management sold 1,100,000 ProKidney shares in Q1 2022, an estimated $10.9M.
  • Park West Asset Management first reported a position in ProKidney in Q2 2021 and held it in 3 quarters.
  • Park West Asset Management's ProKidney position peaked at $11.1M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.

Based on Park West Asset Management's 13F filing for Q1 2022, filed 16 May 2022.